# RESTOR: PK/PD mTORi Inhibition in Older Adults

> **NCT06658093** · EARLY_PHASE1 · RECRUITING · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 194 (estimated)

## Conditions studied

- Aging

## Interventions

- **DRUG:** Rapamycin
- **DRUG:** Everolimus
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06658093
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-13
- **Primary completion:** 2028-07
- **Final completion:** 2028-07
- **Target enrollment:** 194 (ESTIMATED)
- **Last updated:** 2025-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06658093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06658093, "RESTOR: PK/PD mTORi Inhibition in Older Adults". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06658093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*